Skip to content
10-K

Annual Report

USANA HEALTH SCIENCES INC USNA

0000896264-25-000092

← back to feed
Filed
Mar 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2023 · Mar 7, 2025 18.9M sh
Current Liabilities FY 2023 · Dec 30, 2023 $118.85M
Total Liabilities FY 2023 · Dec 30, 2023 $135.56M
Current Assets FY 2023 · Dec 30, 2023 $417.75M
Total Assets FY 2023 · Dec 30, 2023 $632.76M
Shares Diluted FY 2023 · Dec 31, 2022 19.31M sh
Stock Repurchased FY 2023 · Dec 31, 2022 $25.38M
Capex FY 2023 · Dec 31, 2022 $10.4M
Operating Cash Flow FY 2023 · Dec 31, 2022 $103.9M
Cash And Equivalents FY 2023 · Dec 31, 2022 $288.42M
Eps Diluted FY 2023 · Dec 31, 2022 $3.59
Eps Basic FY 2023 · Dec 31, 2022 $3.60
Sga Expense FY 2023 · Dec 31, 2022 $262.3M
Rd Expense FY 2023 · Dec 31, 2022 $11.56M
Net Income FY 2023 · Dec 31, 2022 $69.35M
Operating Income FY 2023 · Dec 31, 2022 $107.61M
Gross Profit FY 2023 · Dec 31, 2022 $804.71M
Cost Of Revenue FY 2023 · Dec 31, 2022 $193.89M
Revenue FY 2023 · Dec 31, 2022 $998.6M
Stockholders Equity FY 2023 · Jan 1, 2022 $395.12M